DESIGN AND CURRENT STATUS OF THE CATZ STUDY: A PHASE III, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO ASSESS THE EFFICACY AND SAFETY OF ADJUNCTIVE ZONISAMIDE IN PEDIATRIC PATIENTS WITH PARTIAL-ONSET SEIZURES

被引：0
|
作者：
Rosati, A. [1 ]
Pellacani, S. [1 ]
van Maanen, R. [2 ]
Segieth, J. [2 ]
Guerrini, R. [1 ]
机构：
[1] Univ Florence, Childrens Hosp Anna Meyer, Florence, Italy
[2] Eisai Ltd, Hatfield, Herts, England
来源：
EPILEPSIA | 2010年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [41] Seizure Freedom with YKP3089 as Adjunctive Therapy for Refractory Partial-Onset Seizures in Double-Blind Placebo-Controlled Trials
    Krauss, Gregory
    French, Jacqueline
    Kamin, Marc
    Ilankumaran, Palanichamy
    NEUROLOGY, 2016, 86
  • [42] Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials
    Biton, Victor
    Gil-Nagel, Antonio
    Isojarvi, Jouko
    Doty, Pamela
    Hebert, David
    Fountain, Nathan B.
    EPILEPSY & BEHAVIOR, 2015, 52 : 119 - 127
  • [43] Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial
    Abedini, Talieh
    Hosseyni, Reyhaneh
    Ghannadi, Farnaz
    Moghaddam, Hossein Sanjari
    Ardakani, Mohammad-Reza Khodaei
    Talaei, Ali
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2022, 76 (10) : 505 - 511
  • [44] Efficacy and safety of lamotrigine extended-release adjunctive therapy in subjects with partial seizures: A randomized, double-blind, placebo-controlled study (ARMOR Study)
    Naritoku, Dean
    Warnock, Clay R.
    Messenheimer, John
    NEUROLOGY, 2007, 68 (12) : A124 - A125
  • [45] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [46] TOLERABILITY OF CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS IN THREE DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Sperling, M. R.
    Faught, E.
    Schmitt, J.
    Wiegand, F.
    Novak, G.
    EPILEPSIA, 2009, 50 : 66 - 66
  • [47] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
    Cuffari, Carmen
    Spalding, William
    Achenbach, Heinrich
    Thakur, Manoj
    Gabriel, Andre
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
  • [48] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
    Hiroyoshi Ohta
    Hiroshi Oka
    Chie Usui
    Masayuki Ohkura
    Makoto Suzuki
    Kusuki Nishioka
    Arthritis Research & Therapy, 14
  • [49] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)
  • [50] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL OF IVIG 10% IN PATIENTS WITH DERMATOMYOSITIS. THE PRODERM STUDY: RESULTS ON EFFICACY AND SAFETY
    Aggarwal, R.
    Charles-Schoeman, C.
    Schessl, J.
    Bata-Csorgo, Z.
    Dimachkie, M.
    Griger, Z.
    Moiseev, S.
    Oddis, C. V.
    Schiopu, E.
    Vencovsky, J.
    Beckmann, I.
    Levine, T.
    Clodi, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 4 - 5
12345